Good Participatory Practice Guidelines for Emerging Pathogens (GPP-EP) help ensure respectful community engagement and strengthen trust through collaborative partnerships. GPP-EP applies across research types and settings, and at all stages of research.
This document is based on GPP-EP guidelines that were prepared by Dr Catherine Hankins for the World Health Organization in December 2016, and is a synthesis of key action points. This “how to” guide, overview, tips and resources will be updated as new resources are completed and approved.
Download the GPP in COVID-19 Clinical Trials toolbox [PDF] HERE
This article is part of our theme area on Good Participatory Practice in COVID-19 Research
This work is licensed under a Creative Commons Attribution 4.0 International License